Published in Arch Dermatol on August 01, 1977
Treatment of subepidermal immunobullous diseases. Clin Dermatol (2011) 0.99
A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid. J Immunol Methods (2009) 0.89
Interleukin-2 production in bullous pemphigoid. Arch Dermatol Res (1984) 0.82
Antigen specificities of antibasement membrane zone antibodies: immunofluorescence and Western immunoblotting studies. Arch Dermatol Res (1988) 0.81
Azathioprine plus prednisone in treatment of pemphigoid. Br Med J (1978) 0.81
Azathioprine in dermatology: a review in the light of advances in understanding methylation pharmacogenetics. J R Soc Med (1995) 0.80
Pemphigoid. Br Med J (1978) 0.75
Suppressor-cell functions in bullous pemphigoid. Arch Dermatol Res (1985) 0.75
Spongiotic intra-epidermal blister: a pitfall in the histopathologic diagnosis of bullous pemphigoid. Indian J Dermatol (2013) 0.75
Dapsone therapy for the acute inflammatory phase of ocular pemphigoid. Br J Ophthalmol (1992) 0.75
Serum and blister fluid immune complexes in bullous pemphigoid: detection with C1q and monoclonal rheumatoid factor. Clin Exp Immunol (1981) 0.75
Absence of anti-Ro and anti-La antibodies in pemphigus and pemphigoid sera. Arch Dermatol Res (1988) 0.75
Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol (1998) 3.68
Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol (1999) 2.50
Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome. Arthritis Rheum (1986) 2.39
Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan. N Engl J Med (1990) 2.37
Subsets in systemic lupus erythematosus. J Invest Dermatol (1979) 2.30
Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis. Brain Pathol (1996) 2.27
Serological findings in patients with "ANA-negative" systemic lupus erythematosus. Medicine (Baltimore) (1981) 2.27
Scleroderma following augmentation mammoplasty. Report of a case and review of the literature. Arch Dermatol (1990) 2.08
Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore) (1985) 2.01
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol (2008) 1.81
Ethylenediamine contact dermatitis. Arch Dermatol (1967) 1.80
Evidence for complement activation via the alternate pathway in skin diseases, I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid. J Clin Invest (1973) 1.73
Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med (1983) 1.68
A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi. J Am Acad Dermatol (1994) 1.64
Epidermolysis bullosa acquisita: ultrastructural and immunological studies. J Invest Dermatol (1981) 1.55
Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region. Proc Natl Acad Sci U S A (1996) 1.54
Prevalence of autoimmune diseases in the family members of patients with pemphigus vulgaris. J Am Acad Dermatol (1994) 1.53
The clinical significance of autoantibodies to a soluble cytoplasmic antigen in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol (1979) 1.51
Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science (1986) 1.50
Neonatal lupus erythematosus: new serologic findings. J Invest Dermatol (1981) 1.49
Demonstration of silicon in sites of connective-tissue disease in patients with silicone-gel breast implants. Arch Dermatol (1993) 1.48
The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma. Br J Cancer (2000) 1.45
High-grade atrioventricular heart block in an adult with systemic lupus erythematosus: the association of nuclear RNP (U1 RNP) antibodies, a case report, and review of the literature. Arthritis Rheum (1989) 1.43
Influence of intravenous immunoglobulin therapy on autoantibody titres to BP Ag1 and BP Ag2 in patients with bullous pemphigoid. J Eur Acad Dermatol Venereol (2003) 1.40
Multiple rhabdomyomatous mesenchymal hamartomas of skin. Am J Dermatopathol (1990) 1.35
Neurologic complications of primary Sjögren's syndrome. Medicine (Baltimore) (1982) 1.34
The immunopathology of herpes gestationis. Immunofluorescence studies and characterization of "HG factor". J Clin Invest (1976) 1.33
Neonatal lupus erythematosus. A clinical, serological and immunogenetic study with review of the literature. Medicine (Baltimore) (1984) 1.30
Age-related changes in melanocytic naevi. Clin Exp Dermatol (1979) 1.27
Interrelationships of HLA-DR, MB, and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus. Arthritis Rheum (1982) 1.27
The natural history of disappearing bone tumours and tumour-like conditions. Clin Radiol (2001) 1.27
Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc Natl Acad Sci U S A (1995) 1.24
Interleukin-10: biology, role in inflammation and autoimmunity. Ann Allergy Asthma Immunol (1997) 1.23
HLA-DRW4 in 91% of Jewish pemphigus vulgaris patients. Lancet (1979) 1.23
Ventriculo-peritoneal shunt and breast carcinoma. Ann R Coll Surg Engl (2001) 1.20
Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity. Proc Natl Acad Sci U S A (1995) 1.20
Sjögren syndrome: central nervous system manifestations. Neurology (1981) 1.15
Melanomas of the palm, sole, and nailbed: a clinicopathologic study. Cancer (1980) 1.14
Melanotic macules and melanoacanthomas of the lip. A comparative study with census of the basal melanocyte population. Am J Dermatopathol (1987) 1.14
Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus. Oncogene (1996) 1.13
Antibodies to cytoplasmic antigens in lupus erythematosus. Serologic marker for systemic disease. Arthritis Rheum (1977) 1.13
Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just "witnesses of disease"? Exp Dermatol (2006) 1.13
Unusual subepidermal bullous diseases with immunologic features of bullous pemphigoid. Arch Dermatol (1979) 1.12
Pemphigus vegetans. Neumann type and Hallopeau type. Int J Dermatol (1984) 1.12
Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study. Ophthalmology (1999) 1.12
Ovarian cancer in patients with dermatomyositis. Medicine (Baltimore) (1994) 1.11
Primary Sjögren's syndrome and other autoimmune diseases in families. Prevalence and immunogenetic studies in six kindreds. Ann Intern Med (1984) 1.11
Homozygous C2 deficiency, lupus erythematosus, and anti-Ro (SSA) antibodies. Arthritis Rheum (1983) 1.08
Pemphigus vulgaris. Superior sensitivity of monkey esophagus in the determination of pemphigus antibody. Arch Dermatol (1981) 1.08
Corticosteroids: a review with emphasis on complications of prolonged systemic therapy. Ann Allergy (1989) 1.06
Two types of inflammatory vascular disease in Sjögren's syndrome. Differential association with seroreactivity to rheumatoid factor and antibodies to Ro (SS-A) and with hypocomplementemia. Arthritis Rheum (1985) 1.06
Nevus of large spindle and/or epithelioid cells (Spitz's nevus). Arch Dermatol (1978) 1.05
Primary Sjögren's syndrome in men. Clinical, serologic, and immunogenetic features. Am J Med (1986) 1.05
Lymphocyte transformation induced by inorganic and organic mercury. Int Arch Allergy Appl Immunol (1970) 1.04
Immunopathology of bullous pemphigoid. Basement membrane deposition of IgE, alternate pathway components and fibrin. Clin Exp Immunol (1974) 1.04
Primary Sjögren's syndrome with central nervous system disease mimicking multiple sclerosis. Ann Intern Med (1986) 1.04
Demonstration of collagenase and elastase activities in the blister fluids from bullous skin diseases. Comparison between dermatitis herpetiformis and bullous pemphigoid. J Invest Dermatol (1983) 1.04
Sjögren's syndrome. Influence of multiple HLA-D region alloantigens on clinical and serologic expression. Arthritis Rheum (1984) 1.04
Esophagitis dissecans superficialis associated with pemphigus vulgaris. J Am Acad Dermatol (1981) 1.02
Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome. J Rheumatol (1982) 1.02
Histologic evolution of recurrent basal cell carcinoma and treatment implications. J Am Acad Dermatol (1986) 1.01
The relationship of pemphigus to neoplasia. J Am Acad Dermatol (1990) 1.01
Pemphigoid gestationis: a review. Am J Obstet Gynecol (2000) 1.00
Pemphigus and myasthenia gravis. Arch Dermatol (1975) 1.00
Melanoma thickness and histology predict sentinel lymph node status. Am J Surg (2001) 1.00
Correlation of subclasses of IgG with disease activity in pemphigus vulgaris. Dermatology (1994) 0.99
Thrombocytopenia in the neonatal lupus syndrome. Arch Dermatol (1988) 0.99
Detection of pemphigus vulgaris antigen on COLO and SCaBER tumor cell lines by the immunoblot technique. Arch Dermatol Res (1990) 0.99
Dermatomyositis sine myositis: association with malignancy. J Rheumatol (1996) 0.98
Value of immunofluorescent techniques in studies of bullous disease. Am J Dermatopathol (1983) 0.97
Pemphigus foliaceus: a case with serologic features of Senear-Usher syndrome and other autoimmune abnormalities. J Am Acad Dermatol (1982) 0.96
Combined immune deficiency, autoantibody formation, and mucocutaneous candidiasis. Clin Immunol Immunopathol (1973) 0.96
Lupus band test. Int J Dermatol (1981) 0.96
Benefits and risks of intralesional corticosteroid injection in the treatment of dermatological diseases. Clin Exp Dermatol (1995) 0.96
Identification of ocular cicatricial pemphigoid antibody binding site(s) in human beta4 integrin. Invest Ophthalmol Vis Sci (2001) 0.95
Vasculitis in chronic urticaria: an immunopathologic study. J Invest Dermatol (1981) 0.95
Systemic lupus erythematosus: current state of the genetic hypothesis. Semin Arthritis Rheum (1984) 0.94
Peripheral inflammatory vascular disease in Sjögren's syndrome. Association with nervous system complications. Arthritis Rheum (1985) 0.94
Anti-Ro/SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model. In vitro electrophysiologic and immunocytochemical studies. Arthritis Rheum (1992) 0.94
Antinuclear antibody-negative systemic lupus erythematosus. I. Anti-Ro(SSA) and anti-La(SSB) antibodies. J Am Acad Dermatol (1981) 0.94
The effect of aging and chronic sun exposure on human Langerhans cell populations. J Invest Dermatol (1984) 0.93
Pemphigus vulgaris: the role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production. Clin Immunol (2001) 0.93
Intravenous immunoglobulins in the therapy of autoimmune and systemic inflammatory disorders. Ann Allergy Asthma Immunol (1995) 0.93
Influence of treatment on the clinical course of pemphigus vulgaris. J Am Acad Dermatol (1996) 0.93
Familial systemic lupus erythematosus: immunogenetic studies in eight families. Medicine (Baltimore) (1983) 0.93
Neuropsychiatric dysfunction in primary Sjögren's syndrome. Ann Intern Med (1985) 0.93
Cyclophosphamide (Cytoxan). A review on relevant pharmacology and clinical uses. J Am Acad Dermatol (1984) 0.93
Detection of pemphigus-like antigens on tumor cell lines. Arch Dermatol Res (1981) 0.92
Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization. Proc Natl Acad Sci U S A (1996) 0.92
Identical MHC markers in non-Jewish Iranian and Ashkenazi Jewish patients with pemphigus vulgaris: possible common central Asian ancestral origin. Hum Immunol (1997) 0.92
The neonatal lupus syndrome associated with U1RNP (nRNP) antibodies. N Engl J Med (1987) 0.92
Anti-intercellular substance antibodies. Presence in serum samples of 14 patients without pemphigus. Arch Dermatol (1983) 0.92
Relationships of HLA-DR and MT antigens to autoantibody expression in systemic lupus erythematosus. Arthritis Rheum (1983) 0.92
Nailfold biopsy in scleroderma and related disorders. Correlation of histologic, capillaroscopic, and clinical data. Arthritis Rheum (1984) 0.92
Cutaneous manifestations of primary Sjögren's syndrome: a reflection of vasculitis and association with anti-Ro(SSA) antibodies. J Invest Dermatol (1983) 0.91